Company Overview of IASO BioMed, Inc.
IASO BioMed, Inc., a development stage biotechnology company, focuses on researching and developing drugs. The company is developing a drug that would be an alternative to testosterone replacement therapy by stimulating the body’s own production rather than using synthetic hormones and steroids, as well as developing an out of body test to identify Alzheimer’s disease. It is also developing a process for developing an early stage blood or fluid test for Alzheimer’s disease. The company was founded in 2015 and is headquartered in Centennial, Colorado.
7315 East Peakview Avenue
Centennial, CO 80111
Founded in 2015
Key Executives for IASO BioMed, Inc.
IASO BioMed, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
August 18, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact IASO BioMed, Inc., please visit www.iasobiomedusa.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.